Target Name: SIPA1L3
NCBI ID: G23094
Other Name(s): SI1L3_HUMAN | SPAR3 | Signal induced proliferation associated 1 like 3 | KIAA0545 | Signal-induced proliferation-associated 1-like protein 3 | SIPA1-like protein 3 | SPAL3 | spine-associated RapGAP 3 | SPA-1-like 3 | signal induced proliferation associated 1 like 3 | CTRCT45 | SPA-1-like protein 3

SIPA1L3: A Potential Drug Target for Various Diseases

SIPA1L3 (SI1L3_HUMAN), a protein encoded by the human gene SIPA1L3, is a key regulator of the cell signaling pathway known as the TGF-β pathway. This pathway is involved in various cellular processes, including cell growth, differentiation, and inflammation. The SIPA1L3 gene has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The TGF-β pathway is a complex intracellular signaling pathway that is involved in the regulation of cellular processes such as cell growth, differentiation, angiogenesis, and inflammation. The pathway is composed of several transcription factors, including SMAD, KLF1, TGF-β1, and TGF-β2. These transcription factors bind to specific DNA sequences to regulate the expression of target genes.

SIPA1L3 is a key transcription factor that is involved in the regulation of the TGF-β pathway. It is a 21-kDa protein that is expressed in various tissues and cells of the body. SIPA1L3 plays a critical role in the regulation of cellular processes such as cell growth, differentiation, and angiogenesis.

SIPA1L3 is involved in the regulation of cell proliferation by promoting the growth of cells and the formation of new tissues. It has been shown that SIPA1L3 plays a critical role in the regulation of cell proliferation in various tissues, including the brain, heart, and pancreas.

SIPA1L3 is also involved in the regulation of cell differentiation by promoting the transition of cells from a progenitor cell to a different cell type. This process is known as cell plasticity, and it is critical for the development and maintenance of tissues and organs. SIPA1L3 has been shown to play a critical role in the regulation of cell plasticity by promoting the transformation of stem cells into functional tissues.

SIPA1L3 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body. This process is critical for the development of tissues and organs and is often abnormal in diseases such as cancer and neurodegenerative diseases. SIPA1L3 has been shown to play a critical role in the regulation of angiogenesis by promoting the formation of new blood vessels in the body.

In addition to its role in cell proliferation, SIPA1L3 is also involved in the regulation of cellular stress responses. Stress responses are critical for the survival of cells and are often regulated by the TGF-β pathway. SIPA1L3 has been shown to play a critical role in the regulation of cellular stress responses by promoting the regulation of cellular stress responses in response to various stressors, including mechanical, thermal, and chemical stress.

SIPA1L3 is also involved in the regulation of inflammation, which is a critical immune response of the body. SIPA1L3 has been shown to play a critical role in the regulation of inflammation by promoting the regulation of inflammatory responses in response to various types of stimuli, including bacterial and viral infections.

SIPA1L3 is a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, SIPA1L3 has been shown to be involved in the regulation of cancer cell proliferation and has been used as a potential therapeutic agent in various cancer therapies. SIPA1L3 has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and has been used as a potential therapeutic agent in these diseases.

In conclusion, SIPA1L3 is a key regulator of the TGF-β pathway and has been shown to play a critical role in the regulation of cellular processes such as cell growth, differentiation, angiogenesis, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for the development of new therapies for various diseases. Further research is needed to fully understand the role of SIPA1L3 in

Protein Name: Signal Induced Proliferation Associated 1 Like 3

Functions: Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217)

More Common Targets

SIRPA | SIRPAP1 | SIRPB1 | SIRPB2 | SIRPB3P | SIRPD | SIRPG | SIRPG-AS1 | SIRT1 | SIRT2 | SIRT3 | SIRT4 | SIRT5 | SIRT6 | SIRT7 | SIT1 | SIVA1 | SIX1 | SIX2 | SIX3 | SIX3-AS1 | SIX4 | SIX5 | SIX6 | SKA1 | SKA1 complex | SKA2 | SKA2P1 | SKA3 | SKAP1 | SKAP1-AS2 | SKAP2 | Skeletal muscle troponin | SKI | SKIC2 | SKIC3 | SKIC8 | SKIDA1 | SKIL | SKINT1L | SKOR1 | SKOR2 | SKP1 | SKP1P2 | SKP2 | SLA | SLA2 | SLAIN1 | SLAIN2 | SLAM Family Member | SLAMF1 | SLAMF6 | SLAMF6P1 | SLAMF7 | SLAMF8 | SLAMF9 | SLBP | SLC corepressor complex | SLC10A1 | SLC10A2 | SLC10A3 | SLC10A4 | SLC10A5 | SLC10A6 | SLC10A7 | SLC11A1 | SLC11A2 | SLC12A1 | SLC12A2 | SLC12A2-DT | SLC12A3 | SLC12A4 | SLC12A5 | SLC12A5-AS1 | SLC12A6 | SLC12A7 | SLC12A8 | SLC12A9 | SLC13A1 | SLC13A2 | SLC13A3 | SLC13A4 | SLC13A5 | SLC14A1 | SLC14A2 | SLC15A1 | SLC15A2 | SLC15A3 | SLC15A4 | SLC15A5 | SLC16A1 | SLC16A10 | SLC16A11 | SLC16A12 | SLC16A13 | SLC16A14 | SLC16A2 | SLC16A3 | SLC16A4 | SLC16A5